ArticleJournal of medical Internet research2025
The Advanced Confidentiality Engine as a Scalable Tool for the Pseudonymization of Biomedical Data in Translational Settings: Development and Usability Study.
Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPseudonymization refers to a process in which data that directly identify individuals, such as names and addresses, are stored separately from data needed for scientific purposes. The connection between both types of data is maintained through a protected link, represented by pseudonyms. This is a central data protection method in translational research, which enables researchers to collect, process, and share data while adhering to "data protection by design and by default" and data minimization best practices. However, integrating pseudonymization into high-throughput data processing workflows is challenging, and open-source solutions are rare. A typical example is the need to pseudonymize millions of electronic health records for secondary use in translational research platforms.
objectiveThis paper introduces the Advanced Confidentiality Engine (ACE), a highly scalable open-source pseudonymization service focused on creating and managing the protected link between identifying and research data.
methodsACE has been designed to have a lean architecture, consisting of a compact database schema that mimics the design of data warehouses. It is implemented using modern open-source software technologies and provides a Representational State Transfer application programming interface. Among its features are a fine-grained access control mechanism, a domain-based structuring of pseudonyms with attribute inheritance, and a comprehensive audit trail. We performed a structured evaluation to study ACE's scalability under various workload scenarios.
resultsFor generating protected links, ACE supports 9 different pseudonymization algorithms, including approaches based on cryptographic primitives and random number generation. Pseudonyms can be encoded using different alphabets that can be combined with check digits. Pseudonyms can be annotated with metadata, such as validity periods, and those properties can be inherited through a hierarchical domain structure. As all information is persisted by ACE, it supports pseudonymization and depseudonymization, for which access can be controlled individually. Our experiments show that ACE is able to handle around 6000 transactions per second in different workload settings. ACE combines the efficiency of cryptography-based pseudonymization methods with the flexibility of persistence-based approaches.
conclusionsACE is a modern and highly scalable implementation of a pseudonymization service tailored toward the specific requirements in biomedical research. It is available as open-source software. As the space of openly available pseudonymization services is limited, we believe that ACE is valuable to institutions establishing or improving their translational data infrastructure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.